Metallothionein: a game changer in histopathological diagnosis of Wilson disease
Histopathology · 2023-12 · 83 (6) · 936-948
DOI: 10.1111/his.15041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 04.09.2023. Verfasst von Hendrik Wiethoff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Hauptthemen laut MEDLINE: Hepatolenticular Degeneration. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Wilson disease (WD) is a genetic disorder of copper metabolism caused by mutations in the ATP7B gene. Toxic copper accumulation leads to hepatic, neurologic, and psychiatric disorders with variable presentation. Metallothionein (MT) immunohistochemistry was proposed as a diagnostic marker.
Methods
MT immunohistochemistry was performed on liver specimens of WD patients ( n = 64) and control cases ( n = 160) including acute liver failure, steatotic liver disease, autoimmune hepatitis, normal liver, primary biliary cholangitis, primary and secondary sclerosing cholangitis, and progressive familial intrahepatic cholestasis. The optimal cutoff for detection of WD was determined by receiver operating characteristic (ROC) analysis.
Results
At least moderate staining in >50% of hepatocytes was observed in 81% of analysed liver specimens ( n = 56/69) of WD patients, while only five control cases showed this staining pattern. The sensitivity, specificity, and accuracy for a new diagnosis of WD were 85.7%, 96.9%, and 94.9%, respectively. Sensitivity in nonfibrotic patients was 70.6% and this MT pattern was robust in small biopsies. The hepatic copper concentration was similar between MT‐positive and MT‐negative liver samples ( P > 0.05). Zinc treatment may induce hepatocellular MT expression. Kayser–Fleischer rings (50% versus 15%) and neurologic disorders (50% versus 13%) were significantly more prevalent in MT‐negative compared to MT‐positive WD patients, respectively.
Conclusion
MT immunostaining is an excellent biomarker for histological diagnosis of WD, should be incorporated in the diagnostic work‐up of patients with potential WD, and is useful in a modified Leipzig score.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
- Department of Gastroenterology, Infectious Diseases and Intoxication, Internal Medicine IV, Heidelberg University Hospital, Heidelberg, Germany.
- Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
- Department of Internal Medicine, Salem Medical Center, Heidelberg, Germany.
ORCID-Profile: Thomas Longerich
Zitieren
APA
Wiethoff, H., Mohr, I., Fichtner, A., Merle, U., Schirmacher, P., Weiss, K. H., & Longerich, T. (2023). Metallothionein: a game changer in histopathological diagnosis of Wilson disease. Histopathology, 83(6), 936-948. https://doi.org/10.1111/his.15041
Vancouver
Wiethoff H, Mohr I, Fichtner A, Merle U, Schirmacher P, Weiss KH, et al. Metallothionein: a game changer in histopathological diagnosis of Wilson disease. Histopathology. 2023;83(6):936-948. doi:10.1111/his.15041
BibTeX
@article{Wiethoff2023,
author = {Wiethoff, Hendrik and Mohr, Isabelle and Fichtner, Alexander and Merle, Uta and Schirmacher, Peter and Weiss, Karl H and Longerich, Thomas},
title = {Metallothionein: a game changer in histopathological diagnosis of Wilson disease},
journal = {Histopathology},
year = {2023},
volume = {83},
number = {6},
pages = {936--948},
doi = {10.1111/his.15041}
}
EUVIMED